Fulminating Septic Shock from Clostridium Perfringens in an Early Breast Cancer Patient with Severe Myalgia after Docetaxel Treatment
Abstract
Share and Cite
Minisini, A.M.; Menis, J.; Follador, A.; Avellini, C.; Fasola, G. Fulminating Septic Shock from Clostridium Perfringens in an Early Breast Cancer Patient with Severe Myalgia after Docetaxel Treatment. Clin. Pract. 2011, 1, e33. https://doi.org/10.4081/cp.2011.e33
Minisini AM, Menis J, Follador A, Avellini C, Fasola G. Fulminating Septic Shock from Clostridium Perfringens in an Early Breast Cancer Patient with Severe Myalgia after Docetaxel Treatment. Clinics and Practice. 2011; 1(2):e33. https://doi.org/10.4081/cp.2011.e33
Chicago/Turabian StyleMinisini, Alessandro Marco, Jessica Menis, Alessandro Follador, Claudio Avellini, and Gianpiero Fasola. 2011. "Fulminating Septic Shock from Clostridium Perfringens in an Early Breast Cancer Patient with Severe Myalgia after Docetaxel Treatment" Clinics and Practice 1, no. 2: e33. https://doi.org/10.4081/cp.2011.e33
APA StyleMinisini, A. M., Menis, J., Follador, A., Avellini, C., & Fasola, G. (2011). Fulminating Septic Shock from Clostridium Perfringens in an Early Breast Cancer Patient with Severe Myalgia after Docetaxel Treatment. Clinics and Practice, 1(2), e33. https://doi.org/10.4081/cp.2011.e33